LENZ Therapeutics LENZ
NASDAQ LENZ
$4.11 +0.01 (+0.24%)
At close: Nov 11, 2026 · 4:00 PM EST

LENZ Therapeutics (LENZ) Change in Receivables (2025 - 2026)

Updated

LENZ Therapeutics' Change in Receivables was $99,000 in Q2 2026, up 607.1% from the prior quarter.

Analysis

LENZ Therapeutics (LENZ) Change in Receivables (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, LENZ Therapeutics' Change in Receivables was $113,000 through Jun 30, 2026; for FY2025, it was $329,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -188.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -312.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 108.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -52.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 LENZ Therapeutics 128.82 Mn -839.21 Mn 2.93 Mn 471,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 471,000.00
Jun 30, 2026 99,000.00
Mar 31, 2026 14,000.00
Dec 31, 2025 329,000.00
API Access

LENZ Therapeutics Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=LENZ&period=max&api_key=YOUR_API_KEY